Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.944 | 2 | 0 | 2001 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.960 | 2 | 0 | 2003 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2005 | 2012 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2007 | 2012 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2014 | 2014 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2011 | 2016 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.857 | 2 | 0 | 2001 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2016 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2008 | 2019 |